FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pazopanib 400mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ruxolitinib 10mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 6million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bosutinib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Topotecan 250microgram capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pazopanib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 400mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 12million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibritumomab tiuxetan 3.2mg/2ml kit for radiopharmaceutical preparation Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabazitaxel 50mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabazitaxel 60mg/6ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 1g powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 850mg/34ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 56mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 164mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 48mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 60mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 300mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 260mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 96mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 280mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 68mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 44mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 88mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 64mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 240mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 220mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 180mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 40mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 34mg/50ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 36mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 72mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 52mg/100ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 80mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 100mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 120mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 160mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 74mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 2090mg/1000ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 130mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 150mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1450mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1130mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 140mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 82mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 66mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 240mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1640mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 110mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1000mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 220mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1280mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 1850mg/1000ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 200mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 180mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 90mg/250ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 890mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 180mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 100mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ramucirumab 100mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibrutinib 140mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 800mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 500mg/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibrutinib 560mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ramucirumab 500mg/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 1.4g/11.7ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 900mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibrutinib 140mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 1000mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 700mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Durvalumab 500mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 600mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rituximab 500mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibrutinib 420mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ibrutinib 280mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mogamulizumab 20mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Eribulin 880micrograms/2ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 150mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ixazomib 4mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Avapritinib 300mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinflunine 250mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Daratumumab 400mg/20ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tisagenlecleucel 1.2million-600million cells dispersion for infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ixazomib 3mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 150mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Atezolizumab 840mg/14ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 25mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 75mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Avapritinib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Binimetinib 15mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 24 of 26 Next End

This concept is not in any reference sets

Back to Start